Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the merger between INC Research and InVentiv Health, which has created a unique company with both clinical and commercial operations under one roof. Starobová talks about her views on the benefits of conducting clinical trials in the country, how trials in rare diseases and gene therapy are the future, and why she is excited to see more of them in the Czech Republic.
In the future, I would like to see more gene therapies being conducted in the country. This is the future of research and treatment
